The quantity field is empty. Please enter a quantity of 1 or more to add items to your cart.
Description
Overview
α2-Adrenergic receptor agonist. Exhibits over 60-fold greater selectivity for α2A receptors over α2β receptors. Enhances EGF- and PDGF-induced DNA synthesis.
If swallowed, seek medical advice immediately and show this container or label.
Product Usage Statements
Storage and Shipping Information
Ship Code
Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity
Toxic
Hazardous Materials Attention:
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Storage
+2°C to +8°C
Protect from Light
Protect from light
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Documentation
Oxymetazoline Hydrochloride - CAS 151615 - Calbiochem SDS
Makara, G.B., et al. 1995. Eur. J. Pharmacol.287, 43.
Data Sheet
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
α2-Adrenergic receptor agonist. Exhibits over 60-fold greater selectivity for α2A receptors over α2β receptors. Enhances EGF- and PDGF-induced DNA synthesis.
Form
White powder
CAS number
2315-02-8
Chemical formula
C₁₆H₂₄N₂O•HCl
Structure formula
Purity
≥99% by HPLC
Solubility
H₂O (50 mg/ml)
Storage
Protect from light
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity
Toxic
References
Makara, G.B., et al. 1995. Eur. J. Pharmacol.287, 43.